Tuesday, May 13, 2025
8:00 am Check-In & Light Breakfast
8:55 am Chair’s Opening Remarks
Advancing AI-Driven Diagnostics & Enhancing Patient Monitoring to Personalize Treatment Decisions & Improve Long-Term Patient Outcomes
9:00 am Harnessing Novel AI & ML Tools to Revolutionize Patient Diagnostics for Unparalleled Personalized Therapy Opportunities
Synopsis
• Leveraging AI-driven algorithms for standardized ME score calculation and enhancing efficiency in clinical trial operations
• The potential for AI to streamline trial endpoints and address screen failures in IBD studies
• Exploring regulatory challenges and the need for cross-industry collaboration to advance AI and CDx adoption
9:30 am Improving Patient Subtyping with AI-Driven Insights to Unlock Better Insights into IBD Heterogeneity & Smash the Efficacy Ceiling
Synopsis
• Utilizing AI to refine patient subtypes based on molecular and clinical profiles
• Enhancing therapeutic targeting by bridging IBD heterogeneity gaps
• Discovering hidden subgroups to drive better therapy alignment
10:00 am Morning Networking Break
Harnessing AI & Data Integration to Optimize Combination Therapies & Enhance Predictive Accuracy in IBD Care
11:00 am Optimizing Drug Combination Strategies with AI Insights to Enhance Efficacy & Minimize Risks in IBD Treatment
Synopsis
• Predicting optimal drug combinations for better patient outcomes
• Minimizing adverse events by refining combination therapy strategies
• Enhancing therapeutic synergies through data-informed drug pairings
11:30 am Rountable Discussion: Revolutionizing Data Integration & Processing Pipelines to Maximize AI-Powered Predictive Accuracy in IBD Care
Synopsis
• How can pipelines be streamlined to integrate diverse patient datasets?
• Enhancing predictive accuracy by reducing noise in data processing
• Improving patient outcomes by leveraging advanced analytics
12:30 pm Lunch Break & Networking
Leveraging Digital Pathology & Spatial Transcriptomics to Unlock Deeper Molecular Insights & Drive Precision Care in Crohn’s & Colitis
1:30 pm Integrating Spatial Biology & Digital Pathology to Reveal Hidden Patterns & Revolutionize IBD Therapeutics
Synopsis
• Combining digital pathology and spatial transcriptomics for better stratification
• Can biopharma identify actionable molecular targets through spatial mapping?
• Driving therapeutic innovations using integrated molecular insights
2:00 pm Rountable Discussion: Overcoming IBD Heterogeneity with AI-Driven Digital Pathology & Radiology to Optimize Patient Subtyping & Outcomes
Synopsis
• AI to refine patient subtypes based on molecular and clinical profiles
• Enhancing therapeutic targeting by bridging IBD heterogeneity gaps
• Discovering hidden subgroups to drive better therapy alignmen
2:30 pm Afternoon Networking Break
Advancing in Non-Invasive Imaging Technologies to Optimize Patient Monitoring & Treatment Strategies in IBD
3:30 pm Using Ultrasound to Non-Invasively Monitor Patient Progress for Enhanced Clinical Decision Making
Synopsis
• Exploring the use of ultrasound for real-time, non-invasive assessment of therapeutic efficacy in preclinical and clinical settings
• Investigating the role of advanced imaging biomarkers to inform and refine drug development strategies
• Integrating ultrasound technologies into longitudinal monitoring frameworks to improve patient stratification and treatment optimization
4:00 pm Applying Novel Imaging Technologies to Accurately Measure Patient Treatment Progress to Quickly Refine Treatment Strategies
Synopsis
• Implementing imaging technologies to track therapy outcomes for precision surveillance
• Enhancing diagnostic imaging for precision treatment recalibration
• Integrating imaging biomarkers into comprehensive monitoring frameworks